9/23/2026
Clearmind expands U.S. patent portfolio with new applications
Patent applications cover novel combinations of LSD, ketamine, and ibogaine.
Topic archive
adi zuloff shani
2 stories
9/23/2026
Clearmind Medicine files US patents for psychedelic combinations
New patent applications aim to enhance mental health treatments using LSD, ketamine, ibogaine.